市場調查報告書

病理解剖的全球市場:成長·趨勢·預測

Anatomic Pathology Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921944
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
病理解剖的全球市場:成長·趨勢·預測 Anatomic Pathology Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

本報告提供全球病理解剖市場調查,提供市場概要,各產品·服務·用途·各終端用戶的市場規模的變化與預測,市場成長要素及阻礙因素,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 癌症等目標疾病的高患病率
    • 個性化醫學日益受重視
    • 先進病理設備使用率高
  • 市場阻礙因素
    • 嚴格的政府關於病理解剖的規定
    • 缺乏熟練的專業人員
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 產品·各類服務
    • 設備
    • 消耗品
    • 服務
  • 各用途
    • 疾病診斷
    • 藥物研發·開發
    • 其他
  • 各終端用戶
    • 醫院
    • 研究所
    • 診斷研究所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Thermo Fisher Scientific Inc.
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • F. Hoffmann-La Roche Ltd.
    • Agilent Technologies, Inc.
    • Cardinal Health
    • Sakura Finetek USA, Inc.
    • NeoGenomics Laboratories, Inc.
    • BioGenex
    • Bio SB

第7章 市場機會及未來趨勢

目錄
Product Code: 67761

Market Overview

The anatomic pathology market will show rapid growth due to the high incidence of cancer and other target diseases, growing focus on personalized medicine and a substantial number of supporting programs and training modules by government.

There is rapid growth in the geriatric population and the increasing incidence rate of cancer and other chronic diseases. Rising cases of chronic disease and increasing requirements to address the timely diagnosis of medical conditions are driving the market.

Due to the rapid increase in the prevalence of cancer, there is increasing usage of advanced pathology equipment such as staining systems, gross imaging, and digital microscopes that are poised to improve anatomic pathological practices to some extent. Digital imaging solutions also offer specificity and accuracy-related benefits over conventional techniques, which in turn, boosts the service uptake rate in the overall market.

In addition, growing awareness and an increase in the patient pool in developing countries is also driving the growth of the market. Moreover, the increase in healthcare expenditure and the increase in usage of biomarkers during disease diagnosis are also found driving the market.

Scope of the Report

As per the scope of the report, anatomic pathology is a medical specialty that is concerned with the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic and molecular examination of organs and tissues. Anatomic pathology involves visualization of human tissue under a microscope for proper diagnosis of the disease or a pathological condition. Microscopic examination of tissue samples with the help of one or more stains is a standard procedure performed in anatomic pathology.

Key Market Trends

Hospitals Segment is Expected to Dominate the Anatomic Pathology Market During the Forecast Period

Hospitals are expected to dominate the market owing to the high hospitalization rate of cancer patients, coupled with a substantial number of frequent readmissions in hospitals. Moreover, the presence of well-developed infrastructure, as well as well-trained staff in hospital-based pathological laboratories, stimulates the progression of the hospital segment. The segment is also expected to benefit from an increasing number of initiatives undertaken by public and private agencies to promote advanced healthcare systems.

On the other side, a large number of clinical trials through various ongoing projects have spurred the progression of the research laboratories segment. Research laboratories are engaged in offering rapid and comprehensive information about the functioning of diseased tissues, with an overall objective of achieving a high degree of patient satisfaction that is expected to grow in the upcoming future.

North America is Found Leading the Anatomic Pathology Market

North America has been accounted for the largest revenue share due to the presence of major players and supportive government initiatives pertaining to training pathological programs. There is also easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region that are the major factors driving the growth of the market in North America.

Competitive Landscape

Product innovation and ongoing R&D activities to develop advanced technologies have helped in boosting the growth of the market. Various strategies and collaborations are being adopted by these key players to maintain their market share. The key players are found implementing multiple strategies to maintain their significant share in the marketplace during the forecast period. The strategies implemented include collaborative development, business expansion, and product developments.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Cancer and Other Target Diseases
    • 4.2.2 Growing Focus on Personalized Medicine
    • 4.2.3 High Usage of Advanced Pathology Equipment
  • 4.3 Market Restraints
    • 4.3.1 Stringent Government Regulations Pertaining to Anatomic Pathology
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product & Services
    • 5.1.1 Instruments
    • 5.1.2 Consumables
    • 5.1.3 Services
  • 5.2 By Application
    • 5.2.1 Disease Diagnosis
    • 5.2.2 Drug Discovery and Development
    • 5.2.3 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Research Laboratories
    • 5.3.3 Diagnostic Laboratories
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 Quest Diagnostics Incorporated
    • 6.1.3 Laboratory Corporation of America Holdings
    • 6.1.4 F. Hoffmann-La Roche Ltd.
    • 6.1.5 Agilent Technologies, Inc.
    • 6.1.6 Cardinal Health
    • 6.1.7 Sakura Finetek USA, Inc.
    • 6.1.8 NeoGenomics Laboratories, Inc.
    • 6.1.9 BioGenex
    • 6.1.10 Bio SB

7 MARKET OPPORTUNITIES AND FUTURE TRENDS